设计公平、包容和情境化护理的临床实践指南

The BMJ Pub Date : 2025-10-10 DOI:10.1136/bmj-2025-085684
Awa Naghipour, Eva Becher, Marcel Gemander, Sabine Oertelt-Prigione
{"title":"设计公平、包容和情境化护理的临床实践指南","authors":"Awa Naghipour, Eva Becher, Marcel Gemander, Sabine Oertelt-Prigione","doi":"10.1136/bmj-2025-085684","DOIUrl":null,"url":null,"abstract":"Sabine Oertelt-Prigione and colleagues argue that European clinical practice guidelines need standardised, inclusive, sex and gender sensitive development to not only guide healthcare but also drive innovation and research agendas As the global governance of healthcare is being reshaped, a timely opportunity and an urgent need exist to institutionalise standardised, equity focused approaches that embed innovation in the design and delivery of care.1 Clinical practice guidelines (CPGs) are essential to this transformation—they are not only endpoints that translate research into care but can also function as upstream influencers that shape research agendas, funding priorities, and innovation pathways.2 Through inclusive sex, gender, and context sensitive processes, CPGs can act as catalysts for advancing women’s and gender sensitive healthcare by identifying and highlighting persistent gaps in data and care, potentially driving innovation in research and service provision. CPGs can thus have a systemic impact beyond their essential role in clinical care. To successfully enact this upstream role, the CPG development process needs to build on strong, inclusive evidence guaranteed by structural and methodological premises and possibly embrace some technological innovations. Women and gender diverse individuals are under-represented and underserved in clinical research and care. Although sex and gender sensitive medicine is expanding and knowledge gaps are being filled as a result of structural interventions such as funding mandates, policy reforms, and publishing prerequisites,3 implementation into clinical practice is lagging behind. Previous reviews from Canada, the US, and Australia have shown the limited attention to sex/gender in national guidelines.456 Sex and gender were either not systematically mentioned in recommendations or used interchangeably—for example, by using “gender” when considering biological sex. Incorrect use of terminology can reduce the target specificity of healthcare interventions, ultimately disadvantaging already underserved populations.7 Furthermore, a lack of adequate inclusion of female participants …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Designing clinical practice guidelines for equitable, inclusive, and contextualised care\",\"authors\":\"Awa Naghipour, Eva Becher, Marcel Gemander, Sabine Oertelt-Prigione\",\"doi\":\"10.1136/bmj-2025-085684\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sabine Oertelt-Prigione and colleagues argue that European clinical practice guidelines need standardised, inclusive, sex and gender sensitive development to not only guide healthcare but also drive innovation and research agendas As the global governance of healthcare is being reshaped, a timely opportunity and an urgent need exist to institutionalise standardised, equity focused approaches that embed innovation in the design and delivery of care.1 Clinical practice guidelines (CPGs) are essential to this transformation—they are not only endpoints that translate research into care but can also function as upstream influencers that shape research agendas, funding priorities, and innovation pathways.2 Through inclusive sex, gender, and context sensitive processes, CPGs can act as catalysts for advancing women’s and gender sensitive healthcare by identifying and highlighting persistent gaps in data and care, potentially driving innovation in research and service provision. CPGs can thus have a systemic impact beyond their essential role in clinical care. To successfully enact this upstream role, the CPG development process needs to build on strong, inclusive evidence guaranteed by structural and methodological premises and possibly embrace some technological innovations. Women and gender diverse individuals are under-represented and underserved in clinical research and care. Although sex and gender sensitive medicine is expanding and knowledge gaps are being filled as a result of structural interventions such as funding mandates, policy reforms, and publishing prerequisites,3 implementation into clinical practice is lagging behind. Previous reviews from Canada, the US, and Australia have shown the limited attention to sex/gender in national guidelines.456 Sex and gender were either not systematically mentioned in recommendations or used interchangeably—for example, by using “gender” when considering biological sex. Incorrect use of terminology can reduce the target specificity of healthcare interventions, ultimately disadvantaging already underserved populations.7 Furthermore, a lack of adequate inclusion of female participants …\",\"PeriodicalId\":22388,\"journal\":{\"name\":\"The BMJ\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The BMJ\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmj-2025-085684\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj-2025-085684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

Sabine Oertelt-Prigione及其同事认为,欧洲临床实践指南需要标准化、包容性、性别和性别敏感的发展,不仅可以指导医疗保健,还可以推动创新和研究议程。随着全球医疗保健治理的重塑,一个及时的机会和迫切需要存在,将标准化、以公平为重点的方法制度化,将创新嵌入到医疗设计和交付中临床实践指南(cpg)对于这一转变至关重要——它们不仅是将研究转化为护理的终点,而且还可以作为塑造研究议程、资助优先事项和创新途径的上游影响者通过包容性的性别、性别和环境敏感进程,CPGs可以通过识别和强调数据和护理方面的持续差距,成为促进妇女和性别敏感医疗保健的催化剂,从而可能推动研究和服务提供方面的创新。因此,CPGs可以在临床护理中发挥重要作用之外产生系统性影响。为了成功地发挥这一上游作用,CPG开发过程需要建立在强有力的、包容性的证据基础上,这些证据由结构和方法前提保证,并可能包括一些技术创新。妇女和性别多样化的个体在临床研究和护理中代表性不足,服务不足。尽管由于资助授权、政策改革和出版先决条件等结构性干预措施,性别和性别敏感医学正在扩大,知识差距正在填补,但在临床实践中的实施却滞后。先前来自加拿大、美国和澳大利亚的评论表明,国家指南对性/性别的关注有限Sex和gender要么在推荐中没有系统地提及,要么可以互换使用——例如,在考虑生理性别时使用“gender”。不正确使用术语会降低医疗保健干预措施的目标特异性,最终使已经得不到充分服务的人群处于不利地位此外,缺乏足够的女性参与者……
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Designing clinical practice guidelines for equitable, inclusive, and contextualised care
Sabine Oertelt-Prigione and colleagues argue that European clinical practice guidelines need standardised, inclusive, sex and gender sensitive development to not only guide healthcare but also drive innovation and research agendas As the global governance of healthcare is being reshaped, a timely opportunity and an urgent need exist to institutionalise standardised, equity focused approaches that embed innovation in the design and delivery of care.1 Clinical practice guidelines (CPGs) are essential to this transformation—they are not only endpoints that translate research into care but can also function as upstream influencers that shape research agendas, funding priorities, and innovation pathways.2 Through inclusive sex, gender, and context sensitive processes, CPGs can act as catalysts for advancing women’s and gender sensitive healthcare by identifying and highlighting persistent gaps in data and care, potentially driving innovation in research and service provision. CPGs can thus have a systemic impact beyond their essential role in clinical care. To successfully enact this upstream role, the CPG development process needs to build on strong, inclusive evidence guaranteed by structural and methodological premises and possibly embrace some technological innovations. Women and gender diverse individuals are under-represented and underserved in clinical research and care. Although sex and gender sensitive medicine is expanding and knowledge gaps are being filled as a result of structural interventions such as funding mandates, policy reforms, and publishing prerequisites,3 implementation into clinical practice is lagging behind. Previous reviews from Canada, the US, and Australia have shown the limited attention to sex/gender in national guidelines.456 Sex and gender were either not systematically mentioned in recommendations or used interchangeably—for example, by using “gender” when considering biological sex. Incorrect use of terminology can reduce the target specificity of healthcare interventions, ultimately disadvantaging already underserved populations.7 Furthermore, a lack of adequate inclusion of female participants …
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信